Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that ...

For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...

Scientists have made a key breakthrough in treating respiratory diseases by developing a new drug delivery system that ...

Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that ...

IBI363 has received two fast track designations (FTD) from the U.S. FDA and two breakthrough designations (BTD) from the ...

Among the lung cancer population with EGFR mutations, patients with insertions at exon 20 (ex20ins) represent a significant unmet need segment. These patients often have poorer outcomes compared to ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

Updated data on IBI363 monotherapy in patients with advanced NSCLC were reported (ClinicalTrials.gov, NCT05460767). As of the ...

Tell me what you think,'" Wernikoff recalled, "and she said, 'I do think it's cancer.'" Wernikoff was diagnosed with stage-3A lung cancer ... patients access to the treatment.

Discover the NHS’s new pioneering "liquid biopsy" blood test for patients with cancer across England. Learn more.

Cancer patients given experimental treatment that programmes the body to attack rogue cells live 40 per cent longer, major ...